Curriculum

The clinical training for the St. Elizabeth’s Medical Center Hematology and Medical Oncology Fellowship takes place in the following settings:

Dana-Farber Cancer Institute at St. Elizabeth’s Medical Center

St. Elizabeth’s Medical Center, a major teaching hospital of Tufts University School of Medicine, provides patients and families access to some of Boston’s most respected physicians and advanced treatments offering specialized care across a wide span of medical and surgical subspecialties with specialists providing care throughout the Boston region.

Awards and Recognitions

Patients receive tertiary care at our 267-bed main campus in the heart of Boston’s Brighton neighborhood. St. Elizabeth’s Medical Center was founded in 1868 by five laywomen members of the third order of St. Francis to care for women from Boston’s South End. St. Elizabeth’s Medical Center accrued notable recognition in the field of hematology through the excellence and prominence of Dr. Fredrick Stohlman Jr, renown Tufts professor of Medicine and St. Elizabeth's director of research, who once led advancement in the arena of hematopoiesis.

Today, St. Elizabeth’s is consistently recognized for providing the highest quality care to our community. The hematology-oncology services are provided by Dana-Farber Cancer Institute faculty and staff through a collaboration between St. Elizabeth’s Medical Center and Dana-Farber (DFCI at St. Elizabeth’s), including chemotherapy/biologic therapy infusion, radiation, and acute level care within campus. First- and second-yearr fellows are assigned primarily to DFCI at St. Elizabeth’s campus for their continuity clinics and coverage of the hematology-oncology consult service.

Dana-Farber Cancer Institute/Brigham and Women’s Hospital

Established in 1947 and consistently ranked by U.S. News, Dana-Farber Cancer Institute (DFCI) and Brigham and Women’s Hospital are Boston’s premier NCI designated comprehensive cancer center institutions providing a wide spectrum of activities in bench-top, translational, clinical research, and patient care in the Northeast. In addition to performing their core and consult services at St. Elizabeth’s, senior fellows may perform elective rotations at DFCI’s main campus in less common cancers, including sarcoma, melanoma, neuro-oncology, and head and neck cancers. Additionally, third-year fellows will serve on one-month leukemia/BMT service at DFCI’s main campus.